Cadaverine Tartrate

Cadaverine Tartrate

SCHEMBL988008

O=C(O)C(O)C(O)C(=O)O.O=S(=O)(O)O

nearest known ligand 0.71

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3CHRM1CHRM2CHRM3CHRM4ESR1ESR2GABRA1GABRB1GABRG2GBA1HRH1HTR1DHTR2AOPRD1OPRK1OPRM1SLC6A2SLC6A3TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Cadaverine Tartrate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.71
CA5A P35218 1/20 0.43
CA5B Q9Y2D0 1/20 0.43
TP53 P04637 1/20 0.39
CYP2C9 P11712 1/20 0.38
PDE4A P27815 1/20 0.38
NFKB1 P19838 1/20 0.36
CYP2C19 P33261 1/20 0.36
OR51E2 Q9H255 1/20 0.33
LMNA P02545 1/20 0.33
SRC P12931 1/20 0.33
ALDH1A1 P00352 1/20 0.33
THRB P10828 1/20 0.33
RECQL P46063 1/20 0.33
PGD P52209 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
ABCB11 O95342 1/20 0.32
F2 P00734 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cadaverine Tartrate SCHEMBL27547121 0.97 TSHR (0.67) TSHRCA5ACA5BTP53CYP2C9
Cadaverine Tartrate SCHEMBL27906745 0.97 TSHR (0.67) TSHRCA5ACA5BTP53CYP2C9
Cadaverine Tartrate SCHEMBL27906743 0.94 TSHR (0.62) TSHRCA5ACA5BTP53CYP2C9
Cadaverine Tartrate SCHEMBL9345627 0.94 TSHR (0.62) TSHRCA5ACA5BTP53CYP2C9
Cadaverine Tartrate SCHEMBL27491776 0.94 TSHR (0.62) TSHRCA5ACA5BTP53CYP2C9
Cadaverine Tartrate SCHEMBL9345632 0.94 TSHR (0.62) TSHRCA5ACA5BTP53CYP2C9
Cadaverine Tartrate SCHEMBL15924829 0.91 TSHR (0.59) TSHRCA5ACA5BTP53CYP2C9
Cadaverine Tartrate SCHEMBL6009350 0.91 TSHR (0.59) TSHRCA5ACA5BTP53CYP2C9
Cadaverine Tartrate SCHEMBL28754057 0.91 TSHR (0.59) TSHRCA5ACA5BTP53CYP2C9
Cadaverine Tartrate SCHEMBL9437851 0.87 TSHR (0.62) TSHRTP53CYP2C9PDE4ANFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3810075-B1 DEVICE FOR DISPENSING A HAIR DYEING PRODUCT USING A DYE COMPOSITION AND AN OXIDIZING COMPOSITION COMPRISING A SCLEROGLUCAN GUM OREAL (FR) 2023-06-28 EP claimed
US-11603474-B2 Corrosion inhibition system GOODRICH CORPORATION (US) 2023-03-14 US claimed
CN-115627514-A Method for preparing ceramic layer on surface of steel plate in modularized manner 北京石油化工学院 2023-01-20 CN claimed
CN-115053022-A Surface treatment method for aluminum-based member 赛峰航空系统公司 2022-09-13 CN claimed
EP-3892696-A1 CORROSION INHIBITION SYSTEM PRIMERS AND ADHESIVES FOR METAL BOND STRUCTURES Rohr, Inc. (US) 2021-10-13 EP claimed
US-20210309886-A1 CORROSION INHIBITION SYSTEM PRIMERS AND ADHESIVES FOR METAL BOND STRUCTURES ROHR, INC. (US) 2021-10-07 US claimed
EP-3812484-A1 CORROSION INHIBITION SYSTEM Goodrich Corporation (US) 2021-04-28 EP claimed
US-20210115267-A1 CORROSION INHIBITION SYSTEM GOODRICH CORPORATION (US) 2021-04-22 US claimed
US-20200385375-A1 ACID ADDITION SALTS OF PIPERAZINE DERIVATIVES ASCENEURON SA (CH) 2020-12-10 US claimed
CN-109183118-B Method for utilizing coloring agent recovered by coloring and sealing hole of nickel-tin salt and medium water and on-line configuration 佛山市三水雄鹰铝表面技术创新中心有限公司 2020-08-11 CN claimed
CN-109082696-B Nickel tin salt coloring recovery colorant and method for utilizing reclaimed water and on-line configuration thereof 佛山市三水雄鹰铝表面技术创新中心有限公司 2020-08-11 CN claimed
US-20190055233-A1 ACID ADDITION SALTS OF PIPERAZINE DERIVATIVES ASCENEURON SA (CH) 2019-02-21 US claimed
CN-109137037-A Nickel pink salt coloring recycling colorant and Waste water utilization method 佛山市三水雄鹰铝表面技术创新中心有限公司 2019-01-04 CN claimed
EP-2900771-B1 USE OF A POLYMERIC CORROSION INHIBITOR FOR TREATMENT OF ANODIZED METAL SURFACES FRAUNHOFER GES FORSCHUNG (DE) 2016-11-30 EP claimed
US-9334577-B2 Multifunctional coating of aluminium pieces AIRBUS OPERATIONS GMBH (DE) 2016-05-10 US claimed
CN-117904688-A Treatment process method for anodic oxidation dyeing of aluminum alloy 丽岛新能源(安徽)有限公司 2024-04-19 CN disclosed
US-RE49699-E1 Inhibitors of TRPC6 BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2023-10-17 US disclosed
US-4710526-A CATIONIC ACRYLATE POLYMER NATIONAL STARCH AND CHEMICAL CORPORATION (US) 1987-12-01 US disclosed
EP-0143544-A2 Coloured anodised finishes ALCAN INTERNATIONAL LIMITED (CA) 1985-06-05 EP disclosed
US-4305938-A HYPOTENSIVE ABBOTT LABORATORIES (US) 1981-12-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190055233-A1 ACID ADDITION SALTS OF PIPERAZINE DERIVATIVES DNPEP, GAA, SLC30A5 TSHR 4619/4885CA5A 123/4885CA5B 347/4885
US-20200385375-A1 ACID ADDITION SALTS OF PIPERAZINE DERIVATIVES DNPEP, GAA, SLC30A5 TSHR 4619/4885CA5A 123/4885CA5B 347/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.